🔬 Station 2 — Identification of Common Bone Tumours
Osteosarcoma • Osteoclastoma • Chondrosarcoma
🎯 Task
Examine the provided bone tumour gross specimens, images or histopathology slides. Identify each lesion, state the key morphological features supporting your diagnosis, and differentiate the three lesions using their characteristic morphology.
⚡ Model Station Answer
What to say in the exam
- Osteosarcoma: A malignant osteogenic tumour characterized microscopically by malignant tumour cells directly producing osteoid. Grossly it is a destructive, firm to gritty grey-white/tan tumour that may breach the cortex.
- Osteoclastoma / Giant Cell Tumour: An expansile, usually red-brown haemorrhagic lesion. Microscopically there are numerous evenly distributed osteoclast-type multinucleated giant cells among mononuclear stromal cells.
- Chondrosarcoma: A malignant cartilage-forming tumour with a lobulated, grey-white to bluish translucent cartilaginous cut surface. Microscopically it shows atypical chondrocytes in lacunae within malignant chondroid matrix.
- Key differentiation: Osteosarcoma produces malignant osteoid, osteoclastoma shows a giant-cell-rich pattern, and chondrosarcoma produces malignant cartilage.
🔎 Stepwise Procedure / Approach
- Orient the specimen or slide. Decide whether you are looking at gross pathology, low-power histology or a higher-power microscopic field.
- Assess the dominant appearance. On gross specimens look for an expansile versus destructive lesion, colour, margins, cortical involvement and the character of the cut surface.
- Look for the tumour matrix. A hard or gritty bone-forming lesion suggests osteoid production, while a lobulated translucent or bluish-grey lesion suggests cartilaginous matrix.
- Examine the microscopic architecture. Identify osteoid, abundant multinucleated giant cells or lobules of malignant cartilage before focusing on individual cells.
- Identify the hallmark feature. For osteosarcoma confirm malignant cells producing osteoid; for osteoclastoma look for evenly dispersed osteoclast-type giant cells; for chondrosarcoma identify atypical chondrocytes within chondroid matrix.
- Assess malignant morphology where relevant. Look for cellular atypia, pleomorphism, destructive growth or invasion in osteosarcoma and chondrosarcoma.
- State the diagnosis confidently. Name the tumour and immediately support it with the two or three strongest morphological features rather than giving a long theoretical description.
🖼️ Visual Learning
Osteosarcoma vs Osteoclastoma vs Chondrosarcoma — Gross and Microscopic Recognition

🎥 Practical Video
🎥 Practical Demonstration — Osteosarcoma Talking Pot
This gross-pathology demonstration shows how to inspect an osteosarcoma specimen and recognize the destructive tumour morphology expected in a practical pathology station.
📝 Important Viva Questions
Answer: The defining feature is production of osteoid directly by malignant tumour cells.
Answer: Numerous osteoclast-type multinucleated giant cells are distributed among mononuclear stromal cells, usually in a relatively uniform pattern.
Answer: It is typically an expansile lesion with a soft red-brown, haemorrhagic cut surface, often with cystic change and thinning of the cortex.
Answer: Malignant cartilage containing atypical chondrocytes in lacunae, often within a lobulated chondroid matrix, supports the diagnosis.
Answer: It is typically lobulated, glistening grey-white to bluish and translucent, with possible myxoid change and calcification.
Answer: Identify the dominant diagnostic pattern: malignant osteoid in osteosarcoma, numerous osteoclast-type giant cells in osteoclastoma, and malignant cartilage in chondrosarcoma.
Answer: No. It is generally considered a locally aggressive/intermediate bone tumour; it can recur locally and, rarely, metastasize.
